Nutratech prevails in patent case
This article was originally published in The Tan Sheet
Executive SummaryUnder a settlement to its patent infringement lawsuit announced Oct. 19, Syntech International acknowledges the validity and infringement of U.S. patents licensed exclusively to West Caldwell, N.J.-based Nutratech on the use of Citrus aurantium (bitter orange) extract for stimulating thermogenesis, reducing weight and suppressing appetite, Nutratech says. Irvine, Calif.-based Syntech agreed to a permanent injunction, immediately ceasing the import and sale of Citrus aurantium extract and will pay damages to Nutratech based upon its past infringement, according to Nutratech. The firm's Advantra Z thermogenic ingredient contains its proprietary Citrus aurantium extract, covered by a patent it licenses from Zhishin Capital LLC...
You may also be interested in...
Switzerland’s Polyphor has redefined its business strategy and is aiming to become a leaner organization, with a potential first-in-class immuno-oncologic, balixafortide, in late-stage clinical development for breast cancer.
Filing for clinical trial activities in the electronic common technical document format via the Common Electronic Submission Gateway is expected to help sponsors send their information in a secure manner, with reduced transmission times and cost.
The bedding-in period is ending for Europe’s one-year-old system for preventing the circulation of fake medicines, and the scheme is gearing up for a more fully operational stage.